Valproate Metabolites and Hyperammonemia

Open Access

|Jul 1992

The association between valproate metabolism (VPA) and VPA induced hyperammonemia was studied at Hirosaki University Hospital, Japan.

References

Kondo T Ishida M Kaneko S Hirano T Otani K Fukushima Y Is 2-propyl-4-pentonoic acid (4-en), a hepatotoxic metabolite of valproate, responsible for valproateinduced hyperammonemia? Epilepsia 1992 May-Jun 33 3 550 554 10.1111/j.1528-1157.1992.tb01708.x 1350534
Open DOI Search in Google Scholar Back to article
Kaji M Ito M Okuno T Momoi T Sasaki H Yamanaka C Serum copper and zinc levels in epileptic children with valproate treatment Epilepsia 1992 May-Jun 33 3 555 557 10.1111/j.1528-1157.1992.tb01709.x 1592036
Open DOI Search in Google Scholar Back to article
Pappo AS Fields BW Buchanan GR Etiology of red blood cell macrocytosis during childhood: impact of new diseases and therapies Pediatrics 1992 Jun 89 6 Pt 1 1063 1067 1534402
Search in Google Scholar Back to article

Language: English

Page range: 53 - 53

Published on: Jul 1, 1992

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

© 1992 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.